Oligodendrocyte pathophysiology: a new view of schizophrenia.

A recent focus of schizophrenia research is disruption of white-matter integrity as a key facet of this complex disorder. This was spurred, partly, by new imaging modalities, magnetic transfer imaging and diffusion tensor imaging, which showed differences in white-matter integrity and tract coherence in persons with schizophrenia compared to controls. Oligodendrocytes, in particular, have been the subject of increased study after gene microarray analyses revealed that six myelin-related genes specific to oligodendrocytes have decreased expression levels in schizophrenia. Oligodendrocytes have also been shown to be decreased in number in the superior frontal gyrus of subjects with schizophrenia. The MAG knockout mouse, missing a myelin-related gene linked to schizophrenia, may prove to be a useful animal model for the dysmyelination observed in the human disease. Studies currently ongoing on this model have found changes in dendritic branching patterns of pyramidal cells in layer III of the prefrontal cortex. Further characterization of the pathology in these mice is underway.

[1]  J. Roder,et al.  Myelination in the absence of myelin-associated glycoprotein , 1994, Nature.

[2]  D. Kirschner,et al.  Mice deficient for the myelin-associated glycoprotein show subtle abnormalities in myelin. , 1994, Neuron.

[3]  J. Olney,et al.  Glutamate receptor dysfunction and schizophrenia. , 1995, Archives of general psychiatry.

[4]  P. Goldman-Rakic,et al.  Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. , 1995, Archives of general psychiatry.

[5]  S. Potkin,et al.  Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[6]  R. Miledi,et al.  Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[7]  P. Goldman-Rakic,et al.  Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. , 1998, Archives of general psychiatry.

[8]  P. Goldman-Rakic,et al.  Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients: Application of a three‐dimensional, stereologic counting method , 1998, The Journal of comparative neurology.

[9]  S. Hirsch,et al.  Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia , 1998, Journal of neurology, neurosurgery, and psychiatry.

[10]  J. Mcdonald,et al.  Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity , 1998, Nature Medicine.

[11]  E. Bongarzone,et al.  Identification of the Dopamine D3 Receptor in Oligodendrocyte Precursors: Potential Role in Regulating Differentiation and Myelin Formation , 1998, The Journal of Neuroscience.

[12]  M S Buchsbaum,et al.  MRI white matter diffusion anisotropy and PET metabolic rate in schizophrenia , 1998, Neuroreport.

[13]  A. D. de Crespigny,et al.  Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging. , 1999, Archives of general psychiatry.

[14]  P. Goldman-Rakic,et al.  The reduced neuropil hypothesis: a circuit based model of schizophrenia , 1999, Biological Psychiatry.

[15]  P. Somogyi,et al.  Glutamatergic synapses on oligodendrocyte precursor cells in the hippocampus , 2000, Nature.

[16]  P. Kalus,et al.  The dendritic architecture of prefrontal pyramidal neurons in schizophrenic patients , 2000, Neuroreport.

[17]  G J Barker,et al.  In vivo investigation of white matter pathology in schizophrenia with magnetisation transfer imaging , 2000, Journal of neurology, neurosurgery, and psychiatry.

[18]  R. Conley,et al.  Ionotropic glutamate receptors and expression of N-methyl-D-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia. , 2000, The American journal of psychiatry.

[19]  D. Lewis,et al.  Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. , 2000, Archives of general psychiatry.

[20]  Pat Levitt,et al.  Molecular Characterization of Schizophrenia Viewed by Microarray Analysis of Gene Expression in Prefrontal Cortex , 2000, Neuron.

[21]  R. Quarles,et al.  Oligodendrocytes in aging mice lacking myelin‐associated glycoprotein are dystrophic but not apoptotic , 2000, Journal of neuroscience research.

[22]  Richard Reynolds,et al.  The oligodendrocyte precursor cell in health and disease , 2001, Trends in Neurosciences.

[23]  A. Sampson,et al.  Decreased somal size of deep layer 3 pyramidal neurons in the prefrontal cortex of subjects with schizophrenia. , 2001, Archives of general psychiatry.

[24]  M. Weiss,et al.  Nerve conduction abnormalities in aging mice deficient for myelin‐associated glycoprotein , 2001, Muscle & nerve.

[25]  W H Wong,et al.  Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[26]  G J Barker,et al.  Neuropathological abnormalities in schizophrenia: evidence from magnetization transfer imaging. , 2001, Brain : a journal of neurology.

[27]  V. Haroutunian,et al.  N-methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia. , 2001, The American journal of psychiatry.

[28]  N. Uranova,et al.  Electron microscopy of oligodendroglia in severe mental illness , 2001, Brain Research Bulletin.

[29]  Ravi S. Menon,et al.  Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers. , 2002, The American journal of psychiatry.

[30]  K. Nave,et al.  Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination , 2003, Nature Genetics.

[31]  J. Breeze,et al.  Abnormal anterior cingulum in patients with schizophrenia: a diffusion tensor imaging study , 2003, Neuroreport.

[32]  R. Kikinis,et al.  Cingulate fasciculus integrity disruption in schizophrenia: a magnetic resonance diffusion tensor imaging study , 2003, Biological Psychiatry.

[33]  Philip D. Harvey,et al.  White matter changes in schizophrenia: evidence for myelin-related dysfunction. , 2003, Archives of general psychiatry.

[34]  J. Morrison,et al.  Age-related dendritic and spine changes in corticocortically projecting neurons in macaque monkeys. , 2003, Cerebral cortex.

[35]  Patrick R Hof,et al.  Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia , 2003, Biological Psychiatry.

[36]  Peter B. Jones,et al.  Oligodendrocyte dysfunction in schizophrenia and bipolar disorder , 2003, The Lancet.

[37]  C. L. Barr,et al.  Genetic study of the myelin oligodendrocyte glycoprotein (MOG) gene in schizophrenia , 2003, Schizophrenia Research.

[38]  Nora I. Perrone-Bizzozero,et al.  Altered Myelination of the Hippocampal Formation in Subjects with Schizophrenia and Bipolar Disorder , 2004, Neurochemical Research.

[39]  L. Gelbert,et al.  Phencyclidine-induced changes in rat cortical gene expression identified by microarray analysis: implications for schizophrenia , 2004, Neurobiology of Disease.

[40]  Zhiguo Sun,et al.  Anterior cingulum abnormalities in male patients with schizophrenia determined through diffusion tensor imaging. , 2004, The American journal of psychiatry.

[41]  A. Kakita,et al.  Prefrontal Abnormality of Schizophrenia Revealed by DNA Microarray: Impact on Glial and Neurotrophic Gene Expression , 2004, Annals of the New York Academy of Sciences.

[42]  K. Blennow,et al.  Altered thalamic membrane phospholipids in schizophrenia: a postmortem study , 2004, Biological Psychiatry.

[43]  T. Crawford,et al.  Myelin-associated glycoprotein and complementary axonal ligands, gangliosides, mediate axon stability in the CNS and PNS: Neuropathology and behavioral deficits in single- and double-null mice , 2005, Experimental Neurology.

[44]  Vahram Haroutunian,et al.  Variations in myelin and oligodendrocyte-related gene expression across multiple brain regions in schizophrenia: A gene ontology study , 2005, Schizophrenia Research.

[45]  Lin He,et al.  Polymorphisms of myelin-associated glycoprotein gene are associated with schizophrenia in the Chinese Han population , 2005, Neuroscience Letters.

[46]  Kazuo Yamada,et al.  DNA Methylation Status of SOX10 Correlates with Its Downregulation and Oligodendrocyte Dysfunction in Schizophrenia , 2005, The Journal of Neuroscience.

[47]  Lin He,et al.  A family-based association study of the MOG gene with schizophrenia in the Chinese population , 2005, Schizophrenia Research.

[48]  Carl-Fredrik Westin,et al.  DTI and MTR abnormalities in schizophrenia: Analysis of white matter integrity , 2005, NeuroImage.

[49]  S. Skaper,et al.  Dopamine D2 and D3 receptor agonists limit oligodendrocyte injury caused by glutamate oxidative stress and oxygen/glucose deprivation , 2005, Glia.

[50]  C. Aston,et al.  Original Research Article , 2004 .

[51]  C. Matute.  Oligodendrocyte NMDA receptors: a novel therapeutic target. , 2006, Trends in molecular medicine.

[52]  Kazuo Yamada,et al.  A family‐based and case‐control association study of SOX10 in schizophrenia , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[53]  N. Jareborg,et al.  Human QKI, a potential regulator of mRNA expression of human oligodendrocyte-related genes involved in schizophrenia. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[54]  C. Konradi,et al.  Decrease in creatine kinase messenger RNA expression in the hippocampus and dorsolateral prefrontal cortex in bipolar disorder. , 2006, Bipolar disorders.

[55]  Michael J Owen,et al.  Convergent evidence for 2',3'-cyclic nucleotide 3'-phosphodiesterase as a possible susceptibility gene for schizophrenia. , 2006, Archives of general psychiatry.

[56]  Stella Dracheva,et al.  Myelin-associated mRNA and protein expression deficits in the anterior cingulate cortex and hippocampus in elderly schizophrenia patients , 2006, Neurobiology of Disease.

[57]  M. Buchsbaum,et al.  Schizophrenia-associated reduction of neuronal and oligodendrocyte numbers in the anterior principal thalamic nucleus , 2006, Schizophrenia Research.

[58]  L. A. McInnes,et al.  RNA metabolism and dysmyelination in schizophrenia , 2006, Neuroscience & Biobehavioral Reviews.